Cytoplasmic accumulation of NCoR in malignant melanoma: consequences of altered gene repression and prognostic significance
Metrics: PDF 2056 views | HTML 2844 views | ?
Fernando Gallardo1,*, Andreina Padrón2, Ricard Garcia-Carbonell3, Cristina Rius3, Abel González-Perez4, Montserrat Arumí-Uria2, Mar Iglesias2, Lara Nonell5, Beatriz Bellosillo2, Sonia Segura1, Ramon Maria Pujol1, Nuria Lopez-Bigas4,6, Joan Bertran7, Anna Bigas3,*, Lluís Espinosa3,*
1Dermatology Department, Parc de Salut Mar-Hospital del Mar, Barcelona, Spain
2Pathology Department, Parc de Salut Mar-Hospital del Mar, Barcelona, Spain
3Stem Cells and Cancer Research Laboratory, Institut Hospital del Mar Investigacions Mèdiques (IMIM), Barcelona, Spain
4Research Unit on Biomedical Informatics, Department of Experimental and Health Sciences, Universitat Pompeu Fabra, Barcelona, Spain
5Servei d’Anàlisi de Microarrays, Institut Hospital del Mar Investigacions Mèdiques (IMIM), Barcelona, Spain
6Catalan Institution for Research and Advanced Studies (ICREA), Passeig Lluís Companys, Barcelona, Spain
7Universitat de Vic, Universitat Central de Catalunya (UVic-UCC), Vic, Spain
*These authors have contributed equally to this work
Fernando Gallardo, e-mail: firstname.lastname@example.org
Lluís Espinosa, e-mail: email@example.com
Anna Bigas, e-mail: firstname.lastname@example.org
Keywords: NCoR, melanoma progression, IKK, gene transcription
Received: November 24, 2014 Accepted: January 31, 2015 Published: March 19, 2015
Invasive malignant melanoma (MM) is an aggressive tumor with no curative therapy available in advanced stages. Nuclear corepressor (NCoR) is an essential regulator of gene transcription, and its function has been found deregulated in different types of cancer. In colorectal cancer cells, loss of nuclear NCoR is induced by Inhibitor of kappa B kinase (IKK) through the phosphorylation of specific serine residues. We here investigate whether NCoR function impacts in MM, which might have important diagnostic and prognostic significance. By IHC, we here determined the subcellular distribution of NCoR in a cohort of 63 primary invasive MM samples, and analyzed its possible correlation with specific clinical parameters. We therefore used a microarray-based strategy to determine global gene expression differences in samples with similar tumor stage, which differ in the presence of cytoplasmic or nuclear NCoR. We found that loss of nuclear NCoR results in upregulation of a specific cancer-related genetic signature, and is significantly associated with MM progression. Inhibition of IKK activity in melanoma cells reverts NCoR nuclear distribution and specific NCoR-regulated gene transcription. Analysis of public database demonstrated that inactivating NCoR mutations are highly prevalent in MM, showing features of driver oncogene.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.